Traub Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Traub Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$589K	Hold	10,228	–	–	0.53%	47
2026 Q1	$620K	Hold	10,228	–	–	0.62%	44
2025 Q4	$552K	Buy	10,228 +200	+2%	+$9.62K	0.53%	51
2025 Q3	$452K	Buy	10,028 +2,474	+33%	+$116K	0.45%	61
2025 Q2	$350K	Buy	+7,554	New	+$371K	0.32%	70

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Traub Capital Management's BMY Position: Q2 2026 in Review

Traub Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 10,228 shares worth $589K. The position accounts for 0.53% of the portfolio, ranked #47.

Traub Capital Management first reported a position in BMY in Q2 2025 and has held it in 5 quarters since. The position peaked at $620K in Q1 2026. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Traub Capital Management held 10,228 shares of Bristol-Myers Squibb worth $589K as of Q2 2026.
Traub Capital Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.53% of Traub Capital Management's portfolio in Q2 2026, its #47 holding.
Traub Capital Management first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 5 quarters since.
Traub Capital Management's Bristol-Myers Squibb position peaked at $620K in Q1 2026.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Traub Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.